JCS Analytics - We are analysts. We Ask. We Automate. We Discover.

Explore the intricacies of web scraping with Python using advanced techniques to handle dynamic content and multi-page structures. Efficiently extract, clean, and prepare 5K@ADA race results data for analysis with Selenium and BeautifulSoup.

Key Points

• Tools and Setup: Using Selenium and BeautifulSoup for web scraping.
• Dynamic Content: Handling and interacting with dynamic web pages.
• Data Extraction: Extracting data from HTML tables and managing pagination.
• Data Cleaning: Normalizing and preparing data for analysis.

Abstract

Blood glucose monitoring (BGM) through twice daily fingerstick readings has been a fundamental part of tracking and visualizing glucose trends since my type 2 diabetes diagnosis in January 2023. While I now use a continuous glucose monitor (CGM) for continuous tracking, BGM remains an important data source for structured trend analysis, treatment evaluation, and accuracy validation. This project focuses on refining BGM visualizations to align with standardized glucose reporting formats, improving readability and insight into key glucose metrics. The updated approach enhances trend analysis while maintaining the value of fingerstick readings as a reliable reference point.

Key Points

• BGM remains a valuable tool – Despite using a CGM, twice-daily fingerstick readings provide structured data that support trend analysis and treatment evaluation.
• Clear trend visualization – Updated BGM visualizations improve formatting consistency, making it easier to track monthly and daily glucose trends.
• Treatment impact assessment – Data comparisons show significant reductions in average blood glucose and A1c following treatment adjustments.
• Standardized reporting formats – The visualizations now follow structured layouts similar to CGM reports, improving clarity and usability.
• BGM as a complementary data source – Fingerstick readings help verify CGM data, track fasting and postprandial glucose, and provide long-term continuity in data analysis.

The GLP-1 RA market is experiencing rapid growth, fueled by the success of key peptides from Eli Lilly and Novo Nordisk. With new products in development and expanding treatment indications, the market is well positioned for continued advancement. The strategic efforts of these companies, coupled with ongoing innovation and research, are set to drive the future of diabetes management.

Key Points

• Market Surge: GLP-1 RA sales have experienced exponential growth, reflecting increased demand and acceptance in the diabetes treatment landscape.
• Key Drivers: Factors driving this growth include improved patient outcomes, expanded indications, and increased awareness of GLP-1 RA benefits.
• Competitive Landscape: The market is highly competitive, with two pharmaceutical companies investing heavily in GLP-1 RA development and marketing.
• Economic Impact: The rising sales of GLP-1 RAs have significant economic implications, including increased healthcare spending and impacts on insurance coverage.
• Future Outlook: Projections indicate continued robust growth for GLP-1 RA sales, driven by ongoing innovations and expanding therapeutic uses.